From Algorithms to Outcomes: Reviewing AI's Role in Non-Muscle-Invasive Bladder Cancer Recurrence Prediction
- URL: http://arxiv.org/abs/2403.10586v1
- Date: Fri, 15 Mar 2024 17:03:45 GMT
- Title: From Algorithms to Outcomes: Reviewing AI's Role in Non-Muscle-Invasive Bladder Cancer Recurrence Prediction
- Authors: Saram Abbas, Dr Rishad Shafik, Prof Naeem Soomro, Prof Rakesh Heer, Dr Kabita Adhikari,
- Abstract summary: Bladder cancer, the leading urinary tract cancer, is responsible for 15 deaths daily in the UK.
Current tools for predicting recurrence use scoring systems that overestimate risk and have poor accuracy.
Machine learning (ML) techniques have emerged as a promising approach for predicting NMIBC recurrence.
- Score: 0.0
- License: http://creativecommons.org/licenses/by-nc-sa/4.0/
- Abstract: Bladder cancer, the leading urinary tract cancer, is responsible for 15 deaths daily in the UK. This cancer predominantly manifests as non-muscle-invasive bladder cancer (NMIBC), characterised by tumours not yet penetrating the muscle layer of the bladder wall. NMIBC is plagued by a very high recurrence rate of 70-80% and hence the costliest treatments. Current tools for predicting recurrence use scoring systems that overestimate risk and have poor accuracy. Inaccurate and delayed prediction of recurrence significantly elevates the likelihood of mortality. Accurate prediction of recurrence is hence vital for cost-effective management and treatment planning. This is where Machine learning (ML) techniques have emerged as a promising approach for predicting NMIBC recurrence by leveraging molecular and clinical data. This review provides a comprehensive analysis of ML approaches for predicting NMIBC recurrence. Our systematic evaluation demonstrates the potential of diverse ML algorithms and markers, including radiomic, clinical, histopathological, genomic, and biochemical data in enhancing recurrence prediction and personalised patient management. We summarise various prediction tasks, data modalities, and ML models used, highlighting their performance, limitations, and future directions of incorporating cost-effectiveness. Challenges related to generalisability and interpretability of artificial intelligent models are discussed, emphasising the need for collaborative efforts and robust datasets.
Related papers
- Modeling Long Sequences in Bladder Cancer Recurrence: A Comparative Evaluation of LSTM,Transformer,and Mamba [0.0]
This study integrates the advantages of deep learning models for handling long-sequence data with the Cox proportional hazards model.
The LSTM-Cox model is a robust and efficient method for recurrent data analysis and feature extraction,surpassing newer models like Transformer and Mamba.
arXiv Detail & Related papers (2024-05-28T18:38:15Z) - Neural parameter calibration and uncertainty quantification for epidemic
forecasting [0.0]
We apply a novel and powerful computational method to the problem of learning probability densities on contagion parameters.
Using a neural network, we calibrate an ODE model to data of the spread of COVID-19 in Berlin in 2020.
We show convergence of our method to the true posterior on a simplified SIR model of epidemics, and also demonstrate our method's learning capabilities on a reduced dataset.
arXiv Detail & Related papers (2023-12-05T21:34:59Z) - Deep learning methods for drug response prediction in cancer:
predominant and emerging trends [50.281853616905416]
Exploiting computational predictive models to study and treat cancer holds great promise in improving drug development and personalized design of treatment plans.
A wave of recent papers demonstrates promising results in predicting cancer response to drug treatments while utilizing deep learning methods.
This review allows to better understand the current state of the field and identify major challenges and promising solution paths.
arXiv Detail & Related papers (2022-11-18T03:26:31Z) - Automated Segmentation and Recurrence Risk Prediction of Surgically
Resected Lung Tumors with Adaptive Convolutional Neural Networks [3.5413688566798096]
Lung cancer is the leading cause of cancer related mortality by a significant margin.
In this paper, we explore the use of convolutional neural networks (CNNs) for the segmentation and recurrence risk prediction of lung tumors.
To the best of our knowledge, it is the first fully automated segmentation and recurrence risk prediction system.
arXiv Detail & Related papers (2022-09-17T23:06:22Z) - Leveraging Uncertainty in Deep Learning for Pancreatic Adenocarcinoma
Grading [0.0]
Pancreatic cancers have one of the worst prognoses compared to other cancers.
Current manual histological grading for diagnosing pancreatic adenocarcinomas is time-consuming and often results in misdiagnosis.
In digital pathology, AI-based cancer grading must be extremely accurate in prediction and uncertainty quantification.
arXiv Detail & Related papers (2022-06-15T19:53:06Z) - SurvLatent ODE : A Neural ODE based time-to-event model with competing
risks for longitudinal data improves cancer-associated Deep Vein Thrombosis
(DVT) prediction [68.8204255655161]
We propose a generative time-to-event model, SurvLatent ODE, which parameterizes a latent representation under irregularly sampled data.
Our model then utilizes the latent representation to flexibly estimate survival times for multiple competing events without specifying shapes of event-specific hazard function.
SurvLatent ODE outperforms the current clinical standard Khorana Risk scores for stratifying DVT risk groups.
arXiv Detail & Related papers (2022-04-20T17:28:08Z) - Deep-CR MTLR: a Multi-Modal Approach for Cancer Survival Prediction with
Competing Risks [0.4189643331553922]
We present Deep-CR MTLR -- a novel machine learning approach for accurate cancer survival prediction.
We demonstrate improved prognostic performance of the multi-modal approach over single modality predictors in a cohort of 2552 head and neck cancer patients.
arXiv Detail & Related papers (2020-12-10T15:51:47Z) - UNITE: Uncertainty-based Health Risk Prediction Leveraging Multi-sourced
Data [81.00385374948125]
We present UNcertaInTy-based hEalth risk prediction (UNITE) model.
UNITE provides accurate disease risk prediction and uncertainty estimation leveraging multi-sourced health data.
We evaluate UNITE on real-world disease risk prediction tasks: nonalcoholic fatty liver disease (NASH) and Alzheimer's disease (AD)
UNITE achieves up to 0.841 in F1 score for AD detection, up to 0.609 in PR-AUC for NASH detection, and outperforms various state-of-the-art baselines by up to $19%$ over the best baseline.
arXiv Detail & Related papers (2020-10-22T02:28:11Z) - MIA-Prognosis: A Deep Learning Framework to Predict Therapy Response [58.0291320452122]
This paper aims at a unified deep learning approach to predict patient prognosis and therapy response.
We formalize the prognosis modeling as a multi-modal asynchronous time series classification task.
Our predictive model could further stratify low-risk and high-risk patients in terms of long-term survival.
arXiv Detail & Related papers (2020-10-08T15:30:17Z) - Neuro-symbolic Neurodegenerative Disease Modeling as Probabilistic
Programmed Deep Kernels [93.58854458951431]
We present a probabilistic programmed deep kernel learning approach to personalized, predictive modeling of neurodegenerative diseases.
Our analysis considers a spectrum of neural and symbolic machine learning approaches.
We run evaluations on the problem of Alzheimer's disease prediction, yielding results that surpass deep learning.
arXiv Detail & Related papers (2020-09-16T15:16:03Z) - Short Term Blood Glucose Prediction based on Continuous Glucose
Monitoring Data [53.01543207478818]
This study explores the use of Continuous Glucose Monitoring (CGM) data as input for digital decision support tools.
We investigate how Recurrent Neural Networks (RNNs) can be used for Short Term Blood Glucose (STBG) prediction.
arXiv Detail & Related papers (2020-02-06T16:39:44Z)
This list is automatically generated from the titles and abstracts of the papers in this site.
This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.